Cambios musculares en la enfermedad pulmonar obstructiva crónica: La teoría de los compartimientos

Archivos de Bronconeumologia

Volumn 36, Issue 2, 2000, Pages 95-102

  Orozco Levi, M ^a,b   Gea Guiral, J ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BODY COMPOSITION; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; MUSCLE; MUSCLE TONE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

BODY COMPOSITION; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MUSCLE TONUS; MUSCLES; RESPIRATORY MUSCLES;

EID: 0034137842     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30215-5     Document Type: Article

References (73)

1. Strauss MJ, Conrad D, Logerfo JP, Hudson LD, Berrgner M. Cost and outcome of care for patients with chronic obstructive lung disease. Analysis by physician speciality. Med Care 1986; 24: 915-924.
2. Decramer M, Gooselink R, Troosters T, Vercshueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997; 10: 417-423.
3. Intermitten Positive Pressure Breathing Trial Group. Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. Ann Intern Med 1983; 99: 612-620.
4. Decramer M, Gosselink R, Troosters T, Schepers R. Peripheral muscle weakness is associated with reduced survival in COPD [resumen]. Am J Respir Crit Care Med 1998; 157: A19.
5. Decramer M, De Bock V, Dom D. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1958-1964.
6. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell FJM et al. Exercise capacity and ventilatory, circulatory, and sympton limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935-940.
7. Wasserman K, Sue DY, Casaburi R, Moricca RB. Selection criteria for exercise training in pulmonary rehabilitation. Eur Respir J 1989; 7 (Supl): 604-610.
8. Grove A, Lipworth BJ, Reid P, Smith RP, Ingram CG, Jenkins RJ et al. Effects of regular salmeterol on long function and exercise capacity in patients with chronic obstructive pulmonari disease. Thorax 1996; 51: 689-693.
9. Low DE, Trulock EP, Kaiser LR, Pasque MK, Dresler C, Ettinger N et al. Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. J Thora Cardiovasc Surg 1992; 103: 1119-1126.
10. Casaburi R. Decconditioning. En: Fishman AP, editor. Pulmonari rehabilitation. Nueva York: Marcel Dekker, 1996; 213-230.
11. American Thoracic Society/European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: S1-S40.
12. Tangri S, Woolf CR. The breathing pattern in chronic obstructive lung disease during performance of some common daily activities. Chest 1973; 63: 126-127.
13. Celli BR, Rasulo J, Make BJ. Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. N Engl J Med 1986; 314: 1485-1490.
14. Banzett R, Topulos G, Leith DE, Natios C. Bracing arms increases the capacity for sustained hyperpnea. Am Rev Respir Dis 1983; 133: 106-109.
15. Casaburi R, Barstow TJ, Robinson T, Wasserman K. Dynamic and steady state ventilatory and gas exchange responses to arm exercise. Med Sci Sports Exer 1992; 24: 1365-1374.
16. Gosselink R, Trossters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980.
17. Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau R et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-634.
18. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness in upper and lower extremities in COPD patients. Eur Respir J 1998; 12: S345.
19. Schols A, Mostert R, Soeters PB, Wouters E. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991; 46: 695-699.
20. Baarends EM, Schols A, Mostert R, Wouters E. Peak exercise in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2807-2813.
21. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity and exercise capacity in patients with cardio-respiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-2031.
22. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am Rev Respir Dis 1994; 150: 11-16.
23. Troosters T, Gosselink R, Rollier H, Decramer M. Change in lower limb muscle strength contributes to altered six minute walking distance in COPD. Eur Respir J 1996; 9: S144.
24. Simpson K, Killian KJ, McCartney N, Stubbing DG, Jones NL. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992; 47: 70-75.
25. Orozco-Levi M, Gea J, Maldonado D. Función de los músculos espiratorios en pacientes con EPOC: expresión de una miopía sistémica? Arch Bronconeumol 1998; 34: A58.
26. Maltais F, Simard A, Simard C, Tobin J, Desgagnés P, Le Blanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153: 288-293.
27. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143: 9-18.
28. Patessio A, Casaburi R, Carone M, Appendini L, Donner CF, Wasserman K. Comparison of gas exchange, lactate, and lactic acidosis thersholds in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 622-626.
29. Evans AB, Al-Himyary AJ, Hrovat MI, Pappagianopoulos P, Wain JC, Ginns LC et al. Abnormal skeletal muscle oxidative capacity after lung transplantation by 3IP-MRS. Am J Respir Crit Care Med 1997; 155: 615-621.
30. Satta A, Migliori GB, Spanevello A, Neri M, Bottinelli R, Canepari M et al. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10: 2853-2860.
31. Maltais F, Leblanc P, Simard J, Jobin C, Berubé J, Bruneau L et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 442-447.
32. Maltais F, Leblanc P, Jobin J, Berube C, Bruneau J, Carrier L et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 555-561.
33. Clark CJ, Cochrane JE, Mackay E. Low intensity peripheral muscle conditioning improves exercise tolerance and brethlessness in COPD. Eur Respir J 1996; 9: 2590-2596.
34. Schols A, Wousters E, Soeters PB, Westertep KR. Body composition by bioelectrical impedance analysis compared to deterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 53: 421-424.
35. Wuyam B, Payen JF, Levy P, Bensaidane H, Reutenauer H, Le Bas JF et al. Metabolism and anaerobic capacity of sleketal muscle in chronic respiratory failure related to chronic obstructive pulmonary diseaes. Eur Respir J 1992; 5: 157-162.
36. Simard C, Maltais F, Leblanc P, Simard PM, Jobin J. Mitochondrial and capillarity changes in vastus lateralis muscle of COPD patients: electron microscopy study. Med Sci Sports Exerc 1996; 28: 95.
37. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S et al. Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Med Sci Sports Exerc 1998; 30: 1467-1474.
38. Hughes RL, Katz H, Sahgal V, Campbell JA, Hartz R, Shields TW. Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung disease. Respiration 1983; 44: 321-328.
39. Hildebrand IL, Sylven C, Esbjonrsson M, Hellstrom K, Jansson E. Does chronic hypoxaemia induce transformation of fibre types? Acta Physiol Scand 1991; 141: 435-439.
40. Jakobsson P, Jordfelt L, Henricksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151: 374-377.
41. Lundgren F, Dahllof AG, Schersten T, Bylund-Fellenius AC. Muscle enzyme adaptation in patients with peripheral insufficiency: spontaneous adaptation, effect of different treatment and consequences on walking performance. Clin Sci 1989; 77: 485-493.
42. Sato Y, Asoh T, Honda Y, Fujimatso Y, Higuchi I, Oizumi K. Morphologic and histochemical evaluation of muscle in patients with chronic pulmonary emphysema manifesting generalized emaciation. Eur Neurol 1997; 37: 116-121.
43. Pastó M. Función respiratoria, proteínas estructurales y actividad enzimática en el diafragma [Tesis doctoral]. Universidad Autónoma de Barcelona, 1988.
44. Orozco-Levi M, Gea J, Aguar M, Sauleda J, Broquetas JM. Adaptación estructural del diafragma en pacientes con enfermedad pulmonar obstructiva crónica. Rev Colomb Neumol 1997; 9: 15-26.
45. Orozco-Levi M, Gea J. El diafragma. Arch Bronconeumol 1997; 33: 399-411.
46. Orozco-Levi M, Gea J. Los músculos respiratorios: nuevos conceptos en anatomía, fisiología y su papel en la enfermedad pulmonar crónica. Rev Colomb Neumol 1996; 18: 190-206.
47. Rochester DF, Braun NMT, Arora NS. Respiratory muscle strength in chronic obstructive pulmonary disease. Am Rev Respir Dis 1979; 119: 151-154.
48. Similowsky T, Yan S, Gauthier AP, Macklem PT. Contractile properties of the human diaphragm. N Engl J Med 1991; 325: 917-923.
49. Orozco-Levi M, Gea J, Lloreta J, Félez M, Minguella J, Serrano S et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 371-378.
50. Lloreta J, Orozco-Levi M, Gea J, Corominas KM, Serrano S. Selective diaphragmatic mitochondrial abnormalities in severe airflow obstruction. Ultrastructural Pathology 1996; 20: 67-71.
51. Orozco-Levi M, Gea J, Lloreta J, Minguella J, Broquetas JM. Changes in the capillary content of the diaphragm in COPD patients: a sort of muscle remodeling? Am J Respir Crit Care Med 1996; 153 (Supl): A298.
52. Orozco-Levi M, Jiménez MA, Gea J, Corominas JM, Broquetas JM. Capillary supply of the respiratory muscles in COPD. Eur Respir J 1996; 9: 158.
53. Hughes RL, Katz H, Sahgal V, Campbell JA, Harz R, Shields TW. Fiber size and energy metabolites in five separate muscles from with chronic obstructive pulmonary disease. Respiration 1983; 44: 321-323.
54. Levine F, Kaiser L, Leferovich J, Tikunov B. Cellular adaptation in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997; 337: 1799-1806.
55. Epstein SK. An overview of respiratory muscle function. En: Belman MJ, editor. Respiratory muscle dysfunction in neuromuscular disease. Clin Chest Med 1994; 15: 619-639.
56. Sauleda J, Orozco-Levi M, Corominas J, Minguella J, Aguar MC, Broquetas J et al. Structure and function relationships of the respiratory muscles. Eur Respir J 1998; 11: 906-911.
57. Orozco-Levi M, Gea J, Aguar MC, Martín-Campos J, Broquetas JM. Changes in myosin expression in the external intercostal muscles of COPD patients. Am J Respir Crit Care Med 1997; 155: A510.
58. Orozco-Levi M, Gea J, Monells J, Arán X, Aguar MC, Broquetas JM. Activity of latissimus dorsi muscle during inspiratory thershold loads. Eur Respir J 1995; 8: 441-445.
59. Orozco-Levi M, Gea J, Sauleda J, Corominas JM, Minguella J, Arán X et al. Structure of the latissimus dorsi muscle respiratory function. J Apply Physiol 1995; 78: 1132-1139.
60. Orozco-Levi M, Gea J, Maldonado D. Proposal for a threshold loading device for the assessment of expiratory muscle function in humans. Am J Respir Crit Care Med 1997; 155: A518.
61. Ferrer A, Barreiro E, Hernández N, Mota S, Palacio J, Orozco-Levi M et al. Cellular properties of the external oblique muscle and expiratory function in patients with severe COPD. Eur Respir J 1999 (en prensa).
62. Pastoris O, Dossena M, Foppa P, Arnaboldi R, Gorini A, Villa RF et al. Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism. Neurochem Res 1995; 20: 143-150.
63. Triveldi B, Danforth WH. Effects of pH on the kinetics of frog muscle phosphofructokinase. J Biol Chem 1966; 10: 4110-4114.
64. Gertz I, Hedenstiema G, Hellers G, Wahren J. Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure. Clin Sci Mol Med 1977; 52: 395-403.
65. Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature 1994; 372: 546-548.
66. Buck M, Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stressin a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 1996; 15: 1753-1765.
67. Jackson MJ, O'Farrel S. Free radicals and muscle damage. Br Med Bull 1993; 49: 630-641.
68. Kondo H, Miura M, Nakagaki I, Sasaki S, Itokawa Y. Trace element movement and oxidative strees in skeletal muscle atrophied by immobilization. Am J Physiol 1992; 262: E593-E590.
69. Flores EA, Bristain BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle metabolism in the rat. J Clin Invest 1989; 83: 1614-1622.
70. Hall-Angeras M, Angeras U, Zamir O, Hasselgren PO, Fischer JE. Interaction between corticosterone and tumor necrosis factor simulated protein breakdown in rat skeletal muscle similar to sepsis. Surgery 1990; 108: 460-466.
71. Jeejeebhoy KN. How should we monitor nutritional support: structure or function? New Horiz 1994; 2: 131-138.
72. Kelsen SG, Ference M, Kapoor S. Effects of prolonged undernutrition on structure and function of the diaphragm. J Appl Physiol 1985; 58: 1354-1359.
73. Lopes J, Russell DM, Whitwell J, Jeejeebhoy KN. Skeletal muscle function in malnutrition. Am J Clin Nutr 1982; 36: 602-610.